Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2014 Sep 28;15(3):177–186.e4. doi: 10.1016/j.clml.2014.09.004

Table 1.

Sociodemographic and clinical characteristics of patients at time of cancer diagnosisa

Characteristic All
(N = 17,457)
Cohort
P
No Follow-up
(n = 16,416)
Follow-up
(n = 1041)
Age group, y .256
 67-75 7175 (41.1) 6825 (41.6) 350 (33.6)
 76-84 7388 (42.3) 6868 (41.8) 520 (49.9)
 ≥ 85 2894 (16.6) 2723 (16.6) 171 (16.4)
Men 8620 (49.4) 8050 (49.0) 570 (54.8) < .001
Race .219
 White 14,152 (80.9) 13,284 (81.0) 868 (83.4)
 Black 2270 (13.1) 2142 (13.1) 128 (12.3)
 Asian 382 (2.2) 364 (2.2) 18 (1.7)
 Hispanic 326 (1.9) 313 (1.9) 13 (1.3)
 American Indian/Alaska native 53 (0.3) ____b ____b
 Other 240 (1.4) 230 (1.4) 10 (1.0)
 Unknown 34 (0.2) ____b ____b
Ethnicity .113
 Hispanic 887 (5.1) 845 (5.1) 42 (4.0)
 Non-Hispanic 16,570 (94.9) 15,571 (94.9) 999 (96.0)
Residence at time of diagnosis .624
 Large metropolitan 10,153 (58.2) 9557 (58.2) 596 (57.3)
 Metropolitan 4677 (26.8) 4380 (26.7) 297 (28.5)
 Urban 972 (5.6) 916 (5.6) 56 (5.4)
 Less urban 1362 (7.8) 1283 (7.8) 79 (7.6)
 Rural ____b ____b ____b
 Unknown ____b ____b ____b
Median annual household income .688
 ≤ $25,000 1579 (9.1) 1483 (9.0) 96 (9.2)
 $25,001-$45,000 7008 (40.1) 6601 (40.2) 407 (39.1)
 $45,001-$65,000 5131 (29.4) 4836 (29.5) 295 (28.3)
 $65,001-$85,000 2265 (13.0) 2122 (12.9) 143 (13.7)
 > $85,000 1364 (7.8) ____b ____b
 Not available 110 (0.6) ____b ____b
Comorbidity score .036
 0 12,054 (69.1) 11,375 (69.3) 679 (65.2)
 1 2817 (16.1) 2636 (16.1) 181 (17.4)
 2 1348 (7.7) 1256 (7.6) 92 (8.8)
 ≥3 1238 (7.1) 1149 (7.0) 89 (8.6)
SEER registry .001
 Atlanta 638 (3.7) 605 (3.7) 33 (3.2)
 Connecticut 1508 (8.6) 1407 (8.6) 101 (9.7)
 Detroit 2012 (11.5) 1888 (11.5) 124 (11.9)
 Greater California 2033 (11.7) 1915 (11.7) 118 (11.3)
 Hawaii 216 (1.2) ____b ____b
 Iowa 1621 (9.3) 1520 (9.3) 101 (9.7)
 Kentucky 964 (5.5) 912 (5.6) 52 (5.0)
 Los Angeles 1613 (9.2) 1542 (9.4) 71 (6.8)
 Louisiana 970 (5.6) 914 (5.6) 56 (5.4)
 New Jersey 2142 (12.3) 2011 (12.3) 131 (12.6)
 New Mexico 476 (2.7) 452 (2.8) 24 (2.3)
 Rural Georgia 49 (0.3) ____b ____b
 San Francisco 785 (4.5) 745 (4.5) 40 (3.8)
 San Jose 498 (2.8) 477 (2.9) 21 (2.0)
 Seattle 1340 (7.7) 1219 (7.4) 121 (11.6)
 Utah 592 (3.4) 560 (3.4) 32 (3.1)
Cancer type < .001
 Lymphoplasmacytic lymphoma 747 (4.3) 701 (4.3) 46 (4.4)
 Multiple myeloma 15,664 (89.7) 14,769 (90.0) 895 (86.0)
 Waldenström macroglobulinemia 1046 (6.0) 946 (5.8) 100 (9.6)
Year of cancer diagnosis < .001
 1994-1999 4744 (27.2) 4551 (27.7) 193 (18.5)
 2000-2007 12,713 (72.8) 11,865 (72.3) 848 (81.5)

Abbreviation: SEER = Surveillance, Epidemiology, and End Results.

a

All statistical tests were 2-sided. Data are presented as number of patients (%).

b

Numbers are suppressed since cell size is less than 11, per SEER-Medicare data reporting requirements.